Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/268013
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
Autor: | Gulen, Theo; Akin, Cem; Bonadonna, Patrizia; Siebenhaar, Frank; Broesby-Olsen, Sigurd; Brockow, Knut; Niedoszytko, Marek; Nedoszytko, Boguslaw; Oude Elberink, Hanneke; Butterfield, Joseph H.; Sperr, Wolfgang R.; Álvarez-Twose, Iván; Horny, Hans-Peter; Sotlar, Karl; Schwaab, Juliana; Jawhar, Mohamad; Zanotti, Roberta; Nilsson, Gunnar; Lyons, Jonathan J.; Carter, Melody C.; George, Tracy I.; Hermine, Olivier; Gotlib, Jason; Orfao, Alberto CSIC ORCID ; Triggiani, Massimo; Reiter, Andreas; Hartmann, Karin; Castells, Mariana; Arock, Michel; Schwartz, Lawrence B.; Metcalfe, Dean D.; Valent, Peter | Palabras clave: | Mast cells MCAS Tryptase Hereditary alpha Tryptasemia Mastocytosis Anaphylaxis Vienna consensus criteria |
Fecha de publicación: | nov-2021 | Editor: | Elsevier | Citación: | Journal of Allergy and Clinical Immunology-In Practice 9(11): 3918-3928 (2021) | Resumen: | In recent years, knowledge about mechanisms underlying mast cell activation (MCA) and accumulation in various pathologic conditions increased substantially. In addition, criteria and a classification of MCA syndromes (MCASs) have been set forth. MCAS is defined by typical clinical symptoms, a substantial increase in serum tryptase level during an attack over the patient's baseline tryptase, and a response of the symptoms to drugs targeting mast cells, mediator production, and/or mediator effects. Alternative diagnostic criteria of MCAS have also been suggested, but these alternative criteria often lack specificity and validation. In this report, we critically review the contemporary literature relating to MCAS and compare the specificity, sensitivity, and strength of MCAS-related parameters within proposals to diagnose and classify MCAS and its variants. Furthermore, we highlight the need to apply specific consensus criteria in the evaluation and classification of MCAS in individual patients. This is an urgent and important medical necessity because as an increasing number of patients are being given a misdiagnosis of MCAS based on nonspecific criteria, which contributes to confusion and frustration by patients and caregivers and sometimes may delay recognition and treatment of correct medical conditions that often turn out to be unrelated to MCA. | Versión del editor: | http://dx.doi.org/10.1016/j.jaip.2021.06.011 | URI: | http://hdl.handle.net/10261/268013 | DOI: | 10.1016/j.jaip.2021.06.011 | E-ISSN: | 2213-2198 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Selecting_the_Right_Criteria_Gulen_PV_Art2021.pdf | 1,21 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
32
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
30
checked on 27-feb-2024
Page view(s)
88
checked on 23-abr-2024
Download(s)
359
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons